1. Updates in Anthracycline-Mediated Cardiotoxicity
    Canan G. Nebigil et al, 2018, Frontiers in Pharmacology CrossRef
  2. Cancer Therapy-Related Cardiovascular Complications in Clinical Practice: Current Perspectives
    Michał Bohdan et al, 2021, Journal of Clinical Medicine CrossRef
  3. Biomarkers in patients after chemotherapy
    F. R. Akildzhonov et al, 2021, Medical alphabet CrossRef
  4. Cardiac imaging in cardiotoxicity: a focus on clinical practice
    George Makavos et al, 2021, Heart Failure Reviews CrossRef
  5. Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers
    Dongqing Chen et al, 2021, Current Heart Failure Reports CrossRef
  6. Cardiotoxicity in HER2-positive breast cancer patients
    Diana Gonciar et al, 2021, Heart Failure Reviews CrossRef
  7. Biomarkers of Early Cardiotoxicity
    Ettore Capoluongo, 2022, Cardio-Oncology CrossRef
  8. Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography
    Hyungseop Kim et al, 2018, Journal of Cardiovascular Ultrasound CrossRef
  9. Preventive use of carvedilol for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials
    T. Zhan et al, 2020, Herz CrossRef
  10. Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
    Lena Hinrichs et al, 2020, Frontiers in Pharmacology CrossRef
  11. Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study
    Dae Hyun Lee et al, 2023, Cardio-Oncology CrossRef
  12. Considerations of Biomarker Application for Cancer Continuum in the Era of Precision Medicine
    Rayjean J. Hung et al, 2022, Current Epidemiology Reports CrossRef
  13. Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics
    Toufik Abdul-Rahman et al, 2023, Current Problems in Cardiology CrossRef
  14. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
    Agata Bikiewicz et al, 2021, ESC Heart Failure CrossRef
  15. Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity
    Jia-Yin Di et al, 2018, Open Life Sciences CrossRef
  16. Kardiovaskuläre Toxizität der Therapie onkologischer Erkrankungen bei Kindern und Jugendlichen
    Ulrich Neudorf et al, 2024, Monatsschrift Kinderheilkunde CrossRef
  17. The Value of Left Atrial Volume Changes in Predicting Cardiotoxicity in Patients Undergoing Anthracycline Chemotherapy
    Dongliang Chen et al, 2022, Journal of Healthcare Engineering CrossRef
  18. Chronic cardiovascular toxicity in the older oncology patient population
    Simon G. Findlay et al, 2019, Journal of Geriatric Oncology CrossRef